Xeris Pharmaceuticals Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2017 | $30 M | No. 4 | $10 to $50 million | equity | SEC | |
| Dec 2015 | $45 M | No. 3 | $10 to $50 million | equity | SEC | |
| Sep 2014 | $7 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jul 2011 | $2 M | No. 1 | Under $2 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Xeris Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (May 2017).
SEC Form D · May 2017
The industry group it chose in its notices: Other.
SEC Form D · May 2017
That is all the official record says: Xeris Pharmaceuticals Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
13 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Barry M. Deutsch | Person | not stated | not stated | Held Series C preferred stock (Form 3, 2018) | SEC Form 3 |
| Deerfield Management Company, L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Deerfield Mgmt III, L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Deerfield Mgmt L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Deerfield Private Design Fund III, L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Deerfield Special Situations Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| John Patrick Shannon Jr. | Person | not stated | not stated | Held Series C preferred stock (Form 3, 2018) | SEC Form 3 |
| Kenneth Erland Johnson | Person | not stated | not stated | Held Series C preferred stock (Form 3, 2018) | SEC Form 3 |
| Palmetto Partners 2014, LP | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Palmetto Partners 2015, LP | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Palmetto Partners, Ltd. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Redmile Group, LLC | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Steven Prestrelski | Person | not stated | not stated | Held Series A and B preferred stock (Form 3, 2018) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 56 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brad Huckabee | Executive officer | May 2017 |
| John Shannon | Executive officer | May 2017 |
| Paul Edick | Executive officer | May 2017 |
| Douglas Baum | Executive officer | Dec 2016 |
| Poul Strange | Executive officer | Dec 2016 |
| Steven Prestrelski | Executive officer | Dec 2016 |
| Phillip Johnson | Executive officer | Jan 2016 |
| Yash Sabharwal | Executive officer | Jan 2016 |
| John Kinzell | Executive officer | Sep 2014 |
| John Kinzel | Executive officer | Oct 2011 |
| Mark Saliman | Executive officer | Jul 2011 |
| Cary McNair | Director | May 2017 |
| Jonathan Rigby | Director | May 2017 |
| Navneet Puri | Director | May 2017 |
| Paul Edick | Director | May 2017 |
| Robert Faulker | Director | May 2017 |
| Douglas Baum | Director | Dec 2016 |
| John Kinzell | Director | Sep 2014 |
| Shane Brisbin | Director | Sep 2014 |
| Timothy Sullivan | Director | Sep 2014 |
| Doug Baum | Director | Oct 2011 |
| John Kinzel | Director | Oct 2011 |
| Steven Prestrelski | Director | Oct 2011 |